HSBC Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.86M | Sell |
6,400
-5,900
| -48% | -$2.75M | ﹤0.01% | 1372 |
|
|
2025
Q4 | $5.6M | Buy |
12,300
+100
| +0.8% | +$43.1K | ﹤0.01% | 1155 |
|
|
2025
Q3 | $4.76M | Buy |
12,200
+400
| +3% | +$167K | ﹤0.01% | 1201 |
|
|
2025
Q2 | $5.24M | Sell |
11,800
-1,400
| -11% | -$645K | ﹤0.01% | 1140 |
|
|
2025
Q1 | $6.31M | Sell |
13,200
-5,100
| -28% | -$2.38M | ﹤0.01% | 1039 |
|
|
2024
Q4 | $7.36M | Buy |
18,300
+1,500
| +9% | +$695K | ﹤0.01% | 1022 |
|
|
2024
Q3 | $7.8M | Hold |
16,800
| – | – | ﹤0.01% | 979 |
|
|
2024
Q2 | $7.99M | Sell |
16,800
-24,200
| -59% | -$10.5M | ﹤0.01% | 921 |
|
|
2024
Q1 | $17.1M | Sell |
41,000
-6,000
| -13% | -$2.54M | 0.01% | 734 |
|
|
2023
Q4 | $19.2M | Buy |
47,000
+800
| +2% | +$296K | 0.02% | 688 |
|
|
2023
Q3 | $16.1M | Buy |
46,200
+15,600
| +51% | +$5.46M | 0.02% | 686 |
|
|
2023
Q2 | $10.7M | Sell |
30,600
-1,900
| -6% | -$640K | 0.01% | 795 |
|
|
2023
Q1 | $10.2M | Buy |
32,500
+21,300
| +190% | +$6.39M | 0.01% | 845 |
|
|
2022
Q4 | $3.19M | Sell |
11,200
-1,200
| -10% | -$366K | ﹤0.01% | 1486 |
|
|
2022
Q3 | $3.62M | Buy |
12,400
+7,400
| +148% | +$2.13M | 0.01% | 1309 |
|
|
2022
Q2 | $1.42M | Buy |
+5,000
| New | +$1.34M | ﹤0.01% | 1761 |
|
|
2021
Q1 | – | Sell |
-25,700
| Closed | -$5.95M | – | 3157 |
|
|
2020
Q4 | $5.95M | Buy |
25,700
+3,300
| +15% | +$757K | 0.01% | 955 |
|
|
2020
Q3 | $6.12M | Sell |
22,400
-1,000
| -4% | -$276K | 0.01% | 878 |
|
|
2020
Q2 | $6.79M | Buy |
23,400
+3,300
| +16% | +$895K | 0.01% | 757 |
|
|
2020
Q1 | $4.76M | Sell |
20,100
-249,000
| -93% | -$57.1M | 0.01% | 860 |
|
|
2019
Q4 | $58.6M | Sell |
269,100
-123,900
| -32% | -$25.1M | 0.1% | 190 |
|
|
2019
Q3 | $66.6M | Buy |
393,000
+7,100
| +2% | +$1.26M | 0.12% | 157 |
|
|
2019
Q2 | $70.8M | Buy |
+385,900
| New | +$67.5M | 0.13% | 144 |
|
|
2019
Q1 | – | Sell |
-15,400
| Closed | -$2.55M | – | 2900 |
|
|
2018
Q4 | $2.55M | Hold |
15,400
| – | – | ﹤0.01% | 1401 |
|
|
2018
Q3 | $2.97M | Sell |
15,400
-1,400
| -8% | -$249K | ﹤0.01% | 1320 |
|
|
2018
Q2 | $2.85M | Hold |
16,800
| – | – | 0.01% | 1367 |
|
|
2018
Q1 | $2.74M | Buy |
+16,800
| New | +$2.74M | ﹤0.01% | 1319 |
|
|
2017
Q4 | – | Sell |
-16,200
| Closed | -$2.46M | – | 2396 |
|
|
2017
Q3 | $2.46M | Buy |
+16,200
| New | +$2.44M | ﹤0.01% | 1249 |
|
|
2016
Q2 | – | Sell |
-500
| Closed | -$40K | – | 2163 |
|
|
2016
Q1 | $40K | Sell |
500
-37,000
| -99% | -$3.35M | ﹤0.01% | 2050 |
|
|
2015
Q4 | $4.72M | Buy |
+37,500
| New | +$4.53M | 0.01% | 965 |
|
|
2015
Q2 | – | Sell |
-27,500
| Closed | -$3.24M | – | 2287 |
|
|
2015
Q1 | $3.24M | Hold |
27,500
| – | – | 0.01% | 1048 |
|
|
2014
Q4 | $3.27M | Buy |
+27,500
| New | +$3.1M | 0.01% | 1029 |
|
Other funds holding VRTX
VCM
VPM
HSBC Holdings's VRTX Position: Q1 2026 in Review
HSBC Holdings increased its Vertex Pharmaceuticals (VRTX) stake by 4% in Q1 2026, buying an estimated $11.7M and bringing the position to 655,443 shares worth $293M. The position accounts for 0.15% of the portfolio, ranked #119.
HSBC Holdings first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $425M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- HSBC Holdings held 655,443 shares of Vertex Pharmaceuticals worth $293M as of Q1 2026.
- HSBC Holdings bought 25,154 Vertex Pharmaceuticals shares in Q1 2026, an estimated $11.7M.
- Vertex Pharmaceuticals made up 0.15% of HSBC Holdings's portfolio in Q1 2026, its #119 holding.
- HSBC Holdings first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- HSBC Holdings's Vertex Pharmaceuticals position peaked at $425M in Q2 2024.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.